HISTOLOGY OF THE NORMAL PARATHYROID GLANDS

  • Embryology and Number
    • Derived from branchial pouches III and IV.
    • Typically four parathyroid glands, though can range from two to six.
    • Lower glands are generally larger than the upper glands.
  • Gross Anatomy
    • Ovoid (bean-shaped) glands measuring about 4–6 mm × 2–4 mm × 0.5–2 mm.
    • Weigh approximately 30 mg each.
    • Color varies from yellow to tan, depending on vascularity and proportion of oxyphil cells and stromal fat.
  • Childhood Gland Composition
    • Sheets of closely packed chief cells, with little stroma.
    • Oxyphil (oncocytic) cells appear at puberty.
    • Fat cells appear in the stroma in late childhood and increase with age.
  • Adult Gland Composition
    • Composed of cords, sheets, and acini of chief cells in a loose areolar stroma containing many mature fat cells.
    • Chief cells may be in:
      • Active (dark) phase: prominent endoplasmic reticulum (ER) and Golgi
      • Resting (light) phase: less developed ER
    • Oxyphil cells are scattered individually or in groups among the chief cells.
  • Chief Cells
    • ~8 μm in diameter.
    • Well-defined cell membrane, centrally located nucleus (~4–5 μm).
    • Nuclei: either densely packed chromatin (almost pyknotic) or finely fibrillar with peripheral margination; nucleoli are rare.
    • Cytoplasm is clear and amphophilic with H&E stain.
    • Periodic acid–Schiff (PAS): abundant glycogen.
    • Also contain abundant neutral lipid droplets (demonstrable by azure B, Erie garnet A, oil red O, or Sudan IV).
    • Immunohistochemistry: stronger parathyroid hormone (PTH) staining than oxyphil cells.
  • Oxyphil (Oncocytic) Cells
    • Larger than chief cells (12–20 μm diameter), polygonal shape.
    • Cell membranes usually clear.
    • Nucleus similar to chief cell nucleus.
    • Cytoplasm: highly eosinophilic, fine granules (stain carmine with Bensley acid aniline fuchsin [BAAF], dark blue with phosphotungstic acid hematoxylin).
    • Packed with mitochondria (hence “oncocytic”).
    • Little intracytoplasmic lipid or glycogen.
    • Transitional oxyphilic cells: smaller, less eosinophilic.
  • Ultrastructure of Chief Cells
    • Chief cells arranged in cords and nests, separated by a basal lamina from the interstitium.
    • Plasma membranes: straight, with desmosomes linking adjacent cells.
    • Active phase:
      • Enlarged Golgi apparatus, numerous vacuoles and vesicles in Golgi region.
      • Many mature secretory granules (50–300 nm).
      • Granules are oval/dumbbell-shaped, with a single membrane, a thin clear space inside, and a dense area of short rodlike profiles.
    • Secretion pathway:
      • Granules move from cell → basement membrane → pericapillary space → capillary basement membrane → fenestrated endothelium → bloodstream (liberating PTH).

PHYSIOLOGY OF THE PARATHYROID GLANDS

  • Primary Function: Regulate and maintain normal serum ionized calcium levels (8.9–10.1 mg/dL).
  • Hormone: Parathyroid hormone (PTH).
  • Regulation:
    • Ionized calcium in blood modulates PTH secretion.
    • Low Ca²⁺ → ↑PTH release; high Ca²⁺ → ↓PTH.
    • Calcium-sensing receptors (CaSRs) on parathyroid glands sense serum Ca²⁺.
    • CaSRs in kidneys also adjust tubular Ca²⁺ reabsorption.
  • Importance of Calcium
    • Critical for neuromuscular function, bone structure, signal transduction (e.g., cytosolic free calcium as second messenger).
    • Hypercalcemia can cause muscle weakness, anorexia, constipation, confusion, coma.
    • Hypocalcemia can cause anxiety, muscle twitching, carpopedal spasm, seizures, stridor, bronchospasm.
  • Calcium Balance
    • Daily dietary Ca²⁺: 300–1500 mg; net GI absorption ~200 mg/day.
    • Urinary Ca²⁺ excretion ~200 mg/day (about 2% of filtered load).
    • Stool Ca²⁺ excretion varies greatly with body needs/diet (normally 500–700 mg/day).
  • Phosphate Metabolism
    • Dietary phosphate: ~800–900 mg/day.
    • GI absorption enhanced by 1,25-dihydroxyvitamin D.
    • Fecal excretion ~30% dietary intake; renal excretion varies inversely with PTH.
  • Homeostatic Mechanisms
    • Low serum Ca²⁺ → parathyroid releases PTH → increased renal 1α-hydroxylation of 25(OH)D → forms 1,25(OH)₂D (calcitriol) → ↑intestinal Ca²⁺ absorption.
    • PTH enhances renal tubule Ca²⁺ reabsorption & bone resorption → net rise in serum Ca²⁺.
    • High serum Ca²⁺ → suppressed PTH secretion → less 1α-hydroxylation → less Ca²⁺ absorption; also more renal Ca²⁺ excretion & reduced bone resorption.
  • Hypoparathyroidism
    • If parathyroids are absent or nonfunctional:
      • Serum Ca²⁺ can fall to ~7 mg/dL, but seldom below 5 mg/dL (body’s skeletal reservoir stabilizes).
  • Effects of Excess PTH
    • Osteoclast activation → bone matrix resorption → mobilization of Ca²⁺ and phosphate.
    • Bone turnover response: osteoclasts & subsequent osteoblastic repair → raised serum alkaline phosphatase.
    • PTH-induced bone resorption is also linked to GI absorption of calcium & phosphate (via upregulated 1,25(OH)₂D).

BONE REMODELING UNIT

  • Overview
    • Bone = collagen matrix + hydroxyapatite (Ca₁₀(PO₄)₆(OH)₂).
    • Modeling (childhood): changes in bone size/shape.
    • Remodeling (lifelong): maintenance/repair via coordinated osteoclast & osteoblast cycles.
  • Bone Cells
    • Osteoblasts: form bone, derived from mesenchymal stem cells.
      • Respond to PTH, 1,25(OH)₂D, estrogen, etc.
      • Secrete collagen & osteoid; become osteocytes or line bone surface or undergo apoptosis.
    • Osteoclasts: multinucleated, large cells from monocyte/macrophage lineage; resorb bone via acid & enzymes.
  • Remodeling Cycle
    1. Resorption (∼2 weeks)
      • Osteoblasts release cytokines (RANK ligand, M-CSF) → osteoclast differentiation → degrade bone mineral & collagen.
      • Self-limited by local factors (high Ca²⁺, TGF-β, etc.).
    2. Reversal (∼4 weeks)
      • Mononuclear cells deposit a cement line & recruit osteoblast precursors.
    3. Formation (∼16 weeks)
      • Osteoblasts lay osteoid until resorbed cavity is refilled.
      • Osteoid → mineralized.
      • Cycle returns to quiescent state.
  • Defective Remodeling
    • Excessive osteoclastic resorption or incomplete osteoblastic refilling → net bone loss.
      • Found in osteoporosis, hyperparathyroidism, etc.
    • Impaired osteoclast function → overly dense bones (osteopetrosis).

Join the
MyEndoConsult Community

We are grateful to the contribution of authors just like you

The MyEndoconsult Team. A group of physicians dedicated to endocrinology and internal medicine education. Learn more about our team

Current Progress
Current Progress
Current Progress
Current Progress
>